Akuta, Norio http://orcid.org/0000-0001-5386-9672
Kawamura, Yusuke
Suzuki, Fumitaka
Kobayashi, Mariko
Arase, Yasuji
Saitoh, Satoshi
Muraishi, Nozomu
Fujiyama, Shunichiro
Sezaki, Hitomi
Hosaka, Tetsuya
Kobayashi, Masahiro
Suzuki, Yoshiyuki
Ikeda, Kenji
Kumada, Hiromitsu
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP21fk0210058, JP21fk0210065, JP21fk0210073, JP21fk0210090)
Article History
Received: 29 August 2021
Accepted: 5 December 2021
First Online: 20 March 2022
Declarations
:
: (1) Hiromitsu Kumada has received honoraria from Gilead Sciences, AbbVie Inc., Eisai Co., Ltd., and Dainippon Sumitomo Pharma. (2) Yusuke Kawamura has received honoraria from Eisai Co., Ltd. Norio Akuta, Yusuke Kawamura, Fumitaka Suzuki, Mariko Kobayashi, Yasuji Arase, Satoshi Saitoh, Nozomu Muraishi, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Yoshiyuki Suzuki, Kenji Ikeda and Hiromitsu Kumada declare that they have no conflicts of interest.
: The study protocol was approved by the Human Ethics Review Committee at Toranomon Hospital, and each patient provided a signed informed consent form at the time of liver histological diagnosis. The study was conducted in compliance with the International Conference on Harmonization Guidelines for Good Clinical Practice (E6) and the 2013 Declaration of Helsinki.
: Not applicable.